Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition
Detailed price information for Agios Pharmaceuticals (AGIO-Q) from The Globe and Mail including charting and trades.
Daily17h
JnJ seeks approval from USFDA, EMA for DARZALEX FASPRO as subcutaneous monotherapy for high-risk smoldering multiple myeloma
Raritan: Johnson & Johnson has announced the submission of regulatory applications to the U.S. Food and Drug Administration ...
Le Lézard4h
Alteogen enters into an Exclusive License Agreement to Develop and Commercialize Subcutaneous ENHERTU® Enabled by Alteogen's Hybrozymetm Technology
Alteogen Inc. (KOSDAQ:196170) announced today that the company has entered into an exclusive license agreement with Daiichi Sankyo (TSE: 4568). Under the terms of the agreement, Daiichi Sankyo will ...
TipRanks on MSN6h
OncoSil Medical Expands Pancreatic Cancer Treatment in Europe
OncoSil Medical Ltd (AU:OSL) has released an update. OncoSil Medical Ltd has achieved a significant milestone with the ...
Australian Broadcasting Corporation22h
Western Australia
Port Hedland is encouraging more female pilots to join WA's multi-billion dollar iron ore industry. Australia takes on Pakistan in the third ODI in Perth, with the series all square at 1-1 ...
NDTV17h
World News
An Afghan delegation will attend the upcoming UN climate change summit in Azerbaijan, the foreign ministry spokesman told AFP on Saturday, marking a first since the Taliban government came to power.